182 related articles for article (PubMed ID: 25481779)
1. Effectiveness of atrial antitachycardia pacing in the treatment of paroxysmal atrial fibrillation in patients with pacemakers.
Silva R; Pereira T; Martins V
Rev Port Cardiol; 2014 Dec; 33(12):781-8. PubMed ID: 25481779
[TBL] [Abstract][Full Text] [Related]
2. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
[TBL] [Abstract][Full Text] [Related]
3. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
[TBL] [Abstract][Full Text] [Related]
4. Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
Russo V; Rago A; Papa AA; Politano L; Golino P; Russo MG; Calabrò R; Nigro G
Kardiol Pol; 2013; 71(11):1147-53. PubMed ID: 24297712
[TBL] [Abstract][Full Text] [Related]
5. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
[TBL] [Abstract][Full Text] [Related]
6. Management of atrial fibrillation in bradyarrhythmias.
Boriani G; Padeletti L
Nat Rev Cardiol; 2015 Jun; 12(6):337-49. PubMed ID: 25781413
[TBL] [Abstract][Full Text] [Related]
7. Programming Pacemakers to Reduce and Terminate Atrial Fibrillation.
Pujol-López M; San Antonio R; Tolosana JM; Mont L
Curr Cardiol Rep; 2019 Sep; 21(10):127. PubMed ID: 31520271
[TBL] [Abstract][Full Text] [Related]
8. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation.
Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA
Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111
[TBL] [Abstract][Full Text] [Related]
9. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
10. Effect of atrial tachyarrhythmia duration on percentage of time with atrial pacing in pacemaker patients with paroxysmal atrial fibrillation.
Schuchert A; Frost G; Meinertz T
J Interv Card Electrophysiol; 2004 Oct; 11(2):143-8. PubMed ID: 15383778
[TBL] [Abstract][Full Text] [Related]
11. Antitachycardia pacing therapies and arrhythmia monitoring diagnostics for the treatment of atrial fibrillation.
Gillis AM; Morck M; Fitts S
Can J Cardiol; 2002 Sep; 18(9):992-5. PubMed ID: 12368934
[TBL] [Abstract][Full Text] [Related]
12. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
Schuster P; Faerestrand S; Ohm OJ
Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
[TBL] [Abstract][Full Text] [Related]
13. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
[TBL] [Abstract][Full Text] [Related]
14. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.
Hemels ME; Ruiter JH; Molhoek GP; Veeger NJ; Wiesfeld AC; Ranchor AV; van Trigt M; Pilmeyer A; Van Gelder IC; ;
Europace; 2008 Mar; 10(3):306-13. PubMed ID: 18245199
[TBL] [Abstract][Full Text] [Related]
15. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up.
Gillis AM; Morck M; Exner DV; Sheldon RS; Duff HJ; Mitchell BL; Wyse GD
Europace; 2009 Aug; 11(8):1041-7. PubMed ID: 19460849
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
[TBL] [Abstract][Full Text] [Related]
17. Device management of arrhythmias after Fontan conversion.
Tsao S; Deal BJ; Backer CL; Ward K; Franklin WH; Mavroudis C
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):937-40. PubMed ID: 19660377
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with cardiac resynchronization therapy devices.
Ueda N; Kamakura T; Noda T; Nakajima K; Kataoka N; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Nagase S; Aiba T; Izumi C; Noguchi T; Yasuda S; Kusano K
J Cardiol; 2020 May; 75(5):559-566. PubMed ID: 31672258
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
[TBL] [Abstract][Full Text] [Related]
20. Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial.
Boriani G; Tukkie R; Biffi M; Mont L; Ricci R; Pürerfellner H; Botto GL; Manolis AS; Landolina M; Gulizia M; Hudnall JH; Mangoni L; Grammatico A; Padeletti L;
Heart Rhythm; 2017 Oct; 14(10):1476-1484. PubMed ID: 28506917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
